Pilot Clinical Trial of IDRACARE® in Moderate to Severe Symptoms of Vulvovaginal Atrophy

NACompletedINTERVENTIONAL

Enrollment

134

Participants

Timeline

Start Date

October 26, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 2, 2022

Conditions

Vulvovaginal Atrophy

Interventions

DEVICE

Idracare

Treatment will last 3 months (12 weeks). The treatment will be applied 2 times a week, preferably at night before going to bed.

Trial Locations (4)

HM Gabinete Velázquez, Madrid

Instituto Palacios de Salud y Medicina de la Mujer, Madrid

HU Miguel Servet, Zaragoza

Clínica Sagrada Familia, Barcelona

All Listed Sponsors

lead

Procare Health Iberia S.L.

INDUSTRY

NCT04766957 - Pilot Clinical Trial of IDRACARE® in Moderate to Severe Symptoms of Vulvovaginal Atrophy | Biotech Hunter | Biotech Hunter